What a Large 2026 Study Reveals About GLP-1 Medications and Hair Loss
Semaglutide hair loss risk emerged as a significant signal in a large propensity-matched cohort study involving hundreds of thousands of patients. Researchers found higher rates of nonscarring hair loss among semaglutide and tirzepatide users compared…
What a Target Trial Emulation Reveals About GLP-1 Safety in Patients With Opiate Use Disorder
This large target trial emulation evaluated GLP-1 safety in opioid use disorder using national claims data. Investigators found no increased risk across ten gastrointestinal, psychiatric, respiratory, and renal outcomes. The findings provide important…
Mounjaro Counterfeit Seizure: GLP-1 Clinical Supply Chain Risks
GLP-1 Clinical Relevance #41Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic NewsSupply Chain InvestigationType 2 DiabetesTirzepatideRegulatory AffairsGlobal Patient PopulationDrug…
Westfield Man Convicted Highlights Synthetic Opioid Contamination Risks
This article discusses synthetic opioid contamination risks in illicit drug supplies, emphasizing patient safety concerns. The Westfield conviction highlights ongoing challenges in harm reduction. Clinicians must remain vigilant about these risks when…
Acute Toxicity of ADB-CHMINACA – Case Series with Pronounced CNS Symptoms
This report presents a series of 16 patients with acute toxicity of ADB-CHMINACA confirmed by analytical testing. Patients exhibited pronounced central nervous system symptoms including panic attacks and seizures. The study highlights the dangers of…
Kratom Cases Surge in the U.S.: Clinical Oversight and Risks
Kratom clinical oversight is increasingly important as cases explode across the U.S. Limited regulation leads to potential drug interactions and withdrawal syndromes. Clinicians should be aware of kratom's opioid-like effects and safety concerns.
Traces of Drugs, Including Cocaine, Found in Sharks: Environmental Study
Pharmaceutical disposal marine contamination is a growing concern as traces of drugs, including cocaine, were found in some shark species. This study highlights the environmental persistence of pharmaceutical waste in marine ecosystems. Understanding…
Increases in Kratom-Related Reports to Poison Centers – CDC
The kratom toxicity profile is increasingly important as poison center reports rise. This signals potential safety concerns for patients using kratom as an opioid alternative. Clinicians should be aware of kratom's drug interactions and toxicity risks.
Can CBD Cause Gynecomastia? Exploring Endocrine Effects and Safety
CBD endocrine effects may influence hormone balance and raise concerns about gynecomastia in males. Current evidence is limited to case reports without definitive causation. Understanding these effects helps guide safe CBD use and patient counseling.
FDA Hesitant to Approve More CBD Based Products
The FDA warning on CBD products addresses potential harm and misinformation surrounding these products. The agency is concerned about unsafe manufacturing and misleading marketing. This caution reflects limited data on CBD's effects and regulatory…